Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-12-01T00:06:49.131Z Has data issue: false hasContentIssue false
  • English
  • Français

Gene Therapy and Infection Control: More Light on the Way

Published online by Cambridge University Press:  02 January 2015

Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Infection Control & Hospital Epidemiology , Volume 21 , Issue 10 , October 2000 , pp. 630 - 632
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2000

References

1. Evans, ME, Lesnaw, JA. Infection control in gene therapy. Infect Control Hosp Epidemiol 1999;20:568–576.Google Scholar
2. Weber, DJ, Rutala, WA. Gene therapy: a new challenge for infection control. Infect Control Hosp Epidemiol 1999;20:530–532.Google Scholar
3. Evans, ME, Jordan, CT, Chang, SMW, Conrad, C, Gerberding, JL, Kaufman, HL, et al. Clinical infection control in gene therapy: a multidisciplinary conference. Infect Control Hosp Epidemiol 2000;21:659–673.Google Scholar
4. The Journal of Gene Medicine Website. The Clinical Trials Website. Charts and Statistics. http://www.wiley.co.uk/genmed/clinical/charts/1countries.html. Last updated May 25, 2000.Google Scholar
5. Giannoukakis, N, Rudert, WA, Robbins, PD, Trucco, M. Targeting autoimmune diabetes with gene therapy. Diabetes 1999;48:2107–2121.Google Scholar
6. Evans, CH, Ghivizzani, SC, Kang, R, Muzzonigro, T, Wasko, MC, Herndon, JH, et al. Gene therapy for rheumatic diseases. Arthritis Rheum 1999;42:1–16.Google Scholar
7. Fueyo, J, Gomez-Manzano, C, Yung, WK, Kyritsis, AP. Targeting in gene therapy for gliomas. Arch Neurol 1999;56:445–448.Google Scholar
8. Freese, A. Restorative gene therapy approaches to Parkinson's disease. Med Clin North Am 1999;83:537–548.Google Scholar
9. Palapattu, GS, Naitoh, J, Belldegrun, AS. Gene therapy for prostate cancer. New perspectives on an old problem. Urol Clin North Am 1999;26:353–363.Google Scholar
10. Hsieh, JT, Dinney, CP, Chung, LW. The potential role of gene therapy in the treatment of bladder cancer. Urol Clin North Am 2000;27:103–113.Google Scholar
11. Scaduto, AA, Lieberman, JR. Gene therapy for osteoinduction. Orthop Clin North Am 1999;30:625–633.Google Scholar
12. Albelda, SM, Wiewrodt, R, Zuckerman, JB. Gene therapy for lung disease: hype or hope? Ann Intern Med 2000;132:649–660.Google Scholar
13. Shetty, K, Wu, GY, Wu, CH. Gene therapy of hepatic diseases: prospects for the new millennium. Gut 2000;46:136–139.CrossRefGoogle ScholarPubMed
14. Duckers, HJ, Nabel, EG. Prospects for genetic therapy of cardiovascular disease. Med Clin North Am 2000;84:199–213.Google Scholar
15. Taub, PJ, Silver, L, Weinberg, H. Plastic surgical perspectives on vascular endothelial growth factor as gene therapy for angiogenesis. Plast Reconstr Surg 2000;105:1034–1042.Google Scholar
16. Smith, AE. Gene therapy—where are we? Lancet 1999;354(suppl 1):SI1–SI4.Google Scholar
17. Stephenson, J. Gene therapy trials show clinical efficacy. JAMA 2000;283:589–590.Google Scholar
18. Barbour, V. The balance of risk and benefit in gene-therapy trials. Lancet 2000;355:384.Google Scholar
19. McCarthy, M. FDA puts US gene-therapy trial on hold. Lancet 2000;355:908–910.Google Scholar
20. Bodenheimer, T. Uneasy alliance: clinical investigators and the pharmaceutical industry. N Engl J Med 2000;342:1539–1544.Google Scholar
21. Stephenson, J. Gene therapy trial oversight. JAMA 2000;283:1950.Google Scholar
22. Israel, BF, Weber, DJ, Rutala, WA. Infection control in gene therapy. In: Mayhall, CG, ed. Hospital Epidemiology and Infection Control. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 1999:1015–1020.Google Scholar